'We have developed novel Chimeric Adapter Proteins (CAPs) that are designed to trigger signaling downstream of the TCRζ chain. CAPs are chimeric molecules that contain adapter domains in tandem with the kinase domain of ZAP70, fused to an extracellular targeting domain.'

#immunotherapy #Preprint

https://www.biorxiv.org/content/10.1101/2022.12.25.521452v1